Does Combined Clinical and Ultrasound Assessment Allow Selection of Individuals With Rheumatoid Arthritis for Sustained Reduction of Anti–Tumor Necrosis Factor Therapy?Jonathan L. Marks, Christopher J Edwards, Christopher Holroyd et al.|Arthritis Care & Research|2015Cited by 31
The effectiveness of a real life dose reduction strategy for tumour necrosis factor inhibitors in ankylosing spondylitis and psoriatic arthritisWarren Fong, Christopher J Edwards, Chris Holroyd et al.|Lara D. Veeken|2016Cited by 27
Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritis.Christopher Holroyd, Christopher J Edwards, Lucy Anne Parker et al.|PubMed|2018Cited by 17
O52 Switching to Biosimilar Infliximab: Real-World Data from the Southampton Biologic Therapies Review ServiceChristopher Holroyd, Christopher J Edwards, Lucy Anne Parker et al.|Lara D. Veeken|2016Cited by 12
EP18 Use of anakinra for haemophagocytic lymphohistiocytosis in adultsLuke Sammut, Christopher J Edwards, Saerrah Murryam et al.|Lara D. Veeken|2020Cited by 4